Subscribe free

HPB & Spleen ·

Normal ca19-9 levels correlate with improved survival in pancreatic cancer

In a study involving 1,558 pancreatic cancer patients, 13.9% exhibited normal carbohydrate antigen 19-9 (ca19-9) levels, linked to significantly longer median survival rates (18.1 vs. 9.7 months). Those with stage IV ca19-9-normal cancer had a 5-year survival chance of 22.4%, compared to 6.8% in the ca19-9-high group. Findings suggest that glucose control, influenced by insulin levels, may provide a new therapeutic avenue in improving overall survival among this indolent subgroup.

Journal Article by Zhu X, Xiao Z (…) Yu X et 8 al. in Ann Surg

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Ann Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

Surg Endosc6 Nov 2026

Robotic bile duct stone surgery: fewer complications

Removing large common bile duct stones with a robot rather than laparoscopically was linked to fewer complications and shorter hospital stays, at a higher cost, in a study from one Chinese hospital.

Br J Surg5 Nov 2026

Rectal cancer and liver spread: similar outcomes

Removing the rectal tumor and liver spread in one operation did not clearly raise complications or hurt survival compared with two separate operations, a French national study found.

All papers in HPB & Spleen →